Prevention Clinical Trials
2 recruiting trials for Prevention. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Prevention clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Health and Medical University Potsdam (1), University of Leipzig (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Cognitive-Behavioral Intervention to increase Self Efficacy (behavioral, 1 trial), followed by Placebo: Weekly Recap and Group Discussion on Psychological Experiments, Cholesterol self-measurement.
Track Prevention trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Prevention of Mental Disorders Through Self-efficacy Interventions
Low self-efficacy is a transdiagnostic risk factor for several mental disorders. Self-efficacy refers to one's belief that one is capable of performing a behavior necessary to...
Cholesterol Self-testing in Patients Post Acute Coronary Syndrome
The pharmacological reduction of LDL-C lowers cardiovascular risk and is therefore a priority in cardiovascular secondary prevention. The achievement of LDL-C target levels in...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Prevention, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Prevention, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Prevention, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.